ProfEdward Gregg

Edward W. Gregg is Head of the RCSI School of Population Health, which aims to guide the key decisions in health policies, promotion and health services through science, education and collaborations.

Prior to coming to RCSI, he served as a Professor and Chair in Diabetes and Cardiovascular Disease Epidemiology in the School of Public Health at Imperial College London since 2019, and before that led a multi-disciplinary public health research unit for chronic diseases at the US Centers for Disease Control and Prevention. He has worked extensively in chronic disease epidemiology and surveillance, prevention effectiveness trials, the development of natural experiments to study health policies, and modelling of health impact and cost-effectiveness of public health interventions. His research has focused on understanding the causes, dynamics and prevention of diabetes and its complications, and includes long-term follow-up studies of lifestyle interventions, as well as the evaluation of US and UK-based public health prevention programmes.

He has led and served in numerous health policy development roles for diabetes and chronic diseases for organisations such as the World Health Organization, Lancet Commission, US CDC and American Diabetes Association. Prof Gregg served as Lead/Chair of the World Health Organization Diabetes Compact Scientific Committee that led to the designation and endorsement of global targets for all WHO member states. It was endorsed by 75th World Health Assembly, WHO and member states and published in The Lancet in March 2023. He served as President (2020-2022) of the International Diabetes Epidemiology Group.

He has published more than 380 peer-reviewed articles and chapters and was awarded the ADA 2016 Kelly West Award for Excellence in Diabetes Epidemiology and the International Diabetes Federation (IDF) 2015 award for Epidemiology award for Epidemiology.